Stockreport

Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF                                                                                                     Global license provides American Regent, a wholly owned subsidiary [Read more]